Publications (33)

2023

  1. Survival after Invasive or Conservative Management of Stable Coronary Disease

    Circulation, Vol. 147, Núm. 1, pp. 8-19

2022

  1. Ranolazine: a better understanding of its pathophysiology and patient profile to guide treatment of chronic stable angina

    Future cardiology, Vol. 18, Núm. 3, pp. 235-251

  2. Tbx5 variants disrupt Nav1.5 function differently in patients diagnosed with Brugada or Long QT Syndrome

    Cardiovascular research, Vol. 118, Núm. 4, pp. 1046-1060

2021

  1. Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation: The GLORIA-AF registry

    Hellenic Journal of Cardiology, Vol. 62, Núm. 2, pp. 152-157

2020

  1. Innate Immune Receptors, Key Actors in Cardiovascular Diseases

    JACC: Basic to Translational Science, Vol. 5, Núm. 7, pp. 735-749

  2. The p.P888L SAP97 polymorphism increases the transient outward current (Ito,f) and abbreviates the action potential duration and the QT interval

    Scientific Reports, Vol. 10, Núm. 1

  3. Comparison of noninvasive cardiac test strategies for newly diagnosed chagas disease in a non-endemic zone

    American Journal of Tropical Medicine and Hygiene, Vol. 103, Núm. 4, pp. 1480-1486

2019

  1. Requisitos y sostenibilidad de los programas de ICP primaria en España en el IAMCEST.: Documento de consenso de SEC, AEEC y SEMES

    REC: Interventional Cardiology, Vol. 1, Núm. 2, pp. 108-119

2018

  1. Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

    The Lancet, Vol. 392, Núm. 10157, pp. 1519-1529

  2. A multicentre randomized pilot trial on the effectiveness of different levels of cooling in comatose survivors of out-of-hospital cardiac arrest: the FROST-I trial

    Intensive Care Medicine, Vol. 44, Núm. 11, pp. 1807-1815

2017

  1. Pharmacological reasons that may explain why randomized clinical trials have failed in acute heart failure syndromes

    International Journal of Cardiology, Vol. 233, pp. 1-11

  2. Tbx20 controls the expression of the KCNH2 gene and of hERG channels

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 114, Núm. 3, pp. E416-E425

2016

  1. Management of stable angina: A commentary on the European Society of Cardiology guidelines

    European Journal of Preventive Cardiology, Vol. 23, Núm. 13, pp. 1401-1412

  2. Quality markers in cardiology: Measures of outcomes and clinical practice - A perspective of the Spanish Society of Cardiology and of Thoracic and Cardiovascular Surgery

    European Heart Journal, Vol. 37, Núm. 1, pp. 12-23

2015

  1. Unresolved issues in the management of chronic stable angina

    International Journal of Cardiology, Vol. 201, pp. 200-207

  2. Use of anticoagulants and antiplatelet agents in stable outpatients with coronary artery disease and atrial fibrillation. International CLARIFY registry

    PLoS ONE, Vol. 10, Núm. 4

  3. Spectral analysis-based risk score enables early prediction of mortality and cerebral performance in patients undergoing therapeutic hypothermia for ventricular fibrillation and comatose status

    International Journal of Cardiology, Vol. 186, pp. 250-258

  4. Quality markers in cardiology: Measures of outcomes and clinical practice - A perspective of the Spanish Society of Cardiology and of Thoracic and Cardiovascular Surgery

    Cirugia Cardiovascular, Vol. 22, Núm. 6, pp. 315-324

2006

  1. EuroHeart Failure Survey II (EHFS II): A survey on hospitalized acute heart failure patients: Description of population

    European Heart Journal, Vol. 27, Núm. 22, pp. 2725-2736

  2. Patients enrolled in coronary intervention trials are not representative of patients in clinical practice: Results from the Euro Heart Survey on Coronary Revascularization

    European Heart Journal, Vol. 27, Núm. 6, pp. 671-678